A Clinical Study to Map the HLA Genomic Region in the Greek Population

NCT06227468 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2024-01-26

No results posted yet for this study

Summary

The aim of GENESIS clinical study is to map the HLA genomic region in the Greek population and evaluate possible correlations with selected underlying diseases.

Conditions

  • Healthy
  • Respiratory Disease
  • Chronic Renal Failure
  • Cardiovascular Diseases
  • Metabolic Disease
  • Psychiatric Disorder
  • Neurologic Disorder
  • Gastrointestinal Diseases
  • Haematologic Disease
  • Rheumatologic Disease

Sponsors & Collaborators

  • Galatea.Bio

    collaborator UNKNOWN
  • Athens LifeTech Park

    lead OTHER

Principal Investigators

  • Efi Giannopoulou · Athens LifeTech Park

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-12
Primary Completion
2025-05-31
Completion
2026-08-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06227468 on ClinicalTrials.gov